This study also demonstrates that EIF4A3 can control tumourigenic capacity of liver cancer cells in vitro and the in vivo tumour growth in a preclinical HCC model of Hep3B‐induced xenografts by the alteration of the expression and splicing events of key oncogenes such as FGFR4. Here, EIF4A3 is linked to liver cancer.